Validation of LUCIO®-Direct-ELISA kits for the detection of drugs of abuse in urine: Application to the new German driving licence re-granting guidelines

Forensic Science International

Volumn 215, Issue 1-3, 2012, Pages 38-45

  Agius, Ronald ^a   Nadulski, Thomas ^a   Moore, Christine ^b  

^a Labor Krone   (Germany)

^b Immunalysis Corporation   (United States)

Author keywords

Abstinence control; Driving licence re granting guidelines; Drug screening; Forensic accreditation; Uncertainty of measurement; Zero tolerance cut offs

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; BENZOYLECGONINE; CANNABIS; COCAINE; CODEINE; DIHYDROCODEINE; METHAMPHETAMINE; MORPHINE; MORPHINE 6 ACETATE; OPIATE; TETRAHYDROCANNABINOLIC ACID; CANNABINOID; NARCOTIC AGENT;

ACCURACY; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRIVER LICENCE; DRUG ABUSE; DRUG SCREENING; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; GAS CHROMATOGRAPHY; GERMANY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MASS SPECTROMETRY; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; URINALYSIS; YOUDEN INDEX; ADDICTION; CAR DRIVING; FORENSIC TOXICOLOGY; LEGAL ASPECT; LICENSING; MASS FRAGMENTOGRAPHY; STANDARD; SUBSTANCE ABUSE; URINE; VALIDATION STUDY;

AMPHETAMINES; AUTOMOBILE DRIVING; CANNABINOIDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FORENSIC TOXICOLOGY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GERMANY; GUIDELINES AS TOPIC; HUMANS; LICENSURE; NARCOTICS; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 84856429304     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2011.10.034     Document Type: Article

References (21)

1. Schubert W., Mattern R. Beurteilungskriterien: Urteilsbildung in der Medizinisch-Psychologischen Fahreignungsdiagnostik 2009, Kirschbaum Verlag, Bonn, p. 178.
2. Peters F.T., Hartung M., Herbold M., Schmitt G., Daldrup T., Mußhoff F. Anlage zu den Richtlinien der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen Anhang C: Anforderungen an die Durchführung von Analysen. 1. Validierung. Toxichem. Krimtech. 2004, 71:146-154.
3. Peters F.T., Hartung M., Herbold M., Schmitt G., Daldrup T., Mußhoff F. Anhang B zur Richtlinien der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen, Anforderungen an die Validierung von Analysenmethoden. Toxichem. Krimtech. 2009, 76:185-208.
4. Mule S.J., Casella G.A. Confirmation of marijuana, cocaine, morphine, codeine, amphetamine, methamphetamine, phencyclidine by GC/MS in urine following immunoassay screening. J. Anal. Toxicol. 1988, 12:102-107.
5. Abraham T.T., Lowe R.H., Pirnay S.O., Darwin W.D., Huestis M.A. Simultaneous GC-EI-MS determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis. J. Anal. Toxicol. 2007, 31:477-485.
6. Schmitt G., Herbold M., Peters F. Qualitätssicherung im forensich-toxikologichen Labor - Auswertung von Validierungsdaten nach den Richtlinien der GTFCh mit VALISTAT 2003, Arvecon GmbH, Walldorf.
7. Agius R., Nadulski T., Kahl H.G., Schrader J., Dufaux B., Yegles M., Pragst F. Validation of a headspace solid-phase microextraction-GC-MS/MS for the determination of ethyl glucuronide in hair according to forensic guidelines. Forensic Sci. Int. 2010, 196:3-9.
8. FDA Guidance for industry: Bioanalytical Method Validation 2001.
9. Macdonald R. Bewertung der Qualität quantitativer analytischer Ergebnisse in der Laboratoriumsmedizin anhand des quadratischen Mittelwertes der Messabweichung. Laboratoriums Medizin. 2006, 30:111-117.
10. DIN 32645 Nachweis-, Erfassung- und Bestimmungsgrenze. Chemical Analysis - Decision Limit, Detection Limit and Determination Limit Under Repeatability Conditions - Terms, Methods, Evaluation 1994, Beuth Verlag, Berlin.
11. Chang B.L., Huang M.K., Tsai Y.Y. Total morphine stability in urine specimens stored under various conditions. J. Anal. Toxicol. 2000, 24:442-447.
12. Dugan S., Bogema S., Schwartz R.W., Lappas N.T. Stability of drugs of abuse in urine samples stored at -20°C. J. Anal. Toxicol. 1994, 18:391-396.
13. Frings C.S., Queen C.A. Stability of certain drugs of abuse in urine specimens. Clin. Chem. 1972, 18:1442.
14. Jimenez C., de la Torre R., Ventura M., Segura J., Ventura R. Stability studies of amphetamine and ephedrine derivatives in urine. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2006, 843:84-93.
15. Cook J.D., Strauss K.A., Caplan Y.H., Lodico C.P., Bush D.M. Urine pH: the effects of time and temperature after collection. J. Anal. Toxicol. 2007, 31:486-496.
16. Kromidas S. Validierung in der Analytik 2000, Wiley, Weinheim. second ed.
17. Zweig M.H., Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 1993, 39:561-577.
18. AS/NZS 4308:2008, Procedures for Specimen Collection and the Detection and Quantitation of Drugs of Abuse In Urine. Standards Australia, 2008.
19. Mandatory Guidelines for Federal Workplace Drug Testing Programs, United States Department of Health and Human Services (HHS), 2008.
20. European Laboratory Guidelines for Legally Defensible Workplace Drug Testing - 1, Urine Drug Testing, European Workplace Drug Testing Society (EWDTS), 2002.
21. Drugs of Abuse Testing Guidelines, Swiss Working Group for Drugs of Abuse Testing Guidelines (AGSA), 2006.